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Abstract. 
 
In polarized cells, signal transduction by 
cholera toxin (CT) requires apical endocytosis and ret-
rograde transport into Golgi cisternae and perhaps ER 
(Lencer, W.I., C. Constable, S. Moe, M. Jobling, H.M. 
Webb, S. Ruston, J.L. Madara, T. Hirst, and R. 
 
Holmes. 1995. 
 
J. Cell Biol. 
 
131:951–962). In this study, 
we tested whether CT’s apical membrane receptor gan-
glioside GM1 acts specifically in toxin action. To do so, 
we used CT and the related 
 
Escherichia coli
 
 heat-labile 
type II enterotoxin LTIIb. CT and LTIIb distinguish 
between gangliosides GM1 and GD1a at the cell sur-
face by virtue of their dissimilar receptor-binding B 
subunits. The enzymatically active A subunits, how-
ever, are homologous. While both toxins bound specifi-
 
cally to human intestinal T84 cells (
 
K
 
d
 
 
 
< 
 
5 nM), only 
 
CT elicited a cAMP-dependent Cl
 
2
 
 secretory response. 
LTIIb, however, was more potent than CT in eliciting a 
cAMP-dependent response from mouse Y1 adrenal 
cells (toxic dose 10 vs. 300 pg/well). In T84 cells, CT 
fractionated with caveolae-like detergent-insoluble 
membranes, but LTIIb did not. To investigate further 
the relationship between the specificity of ganglioside 
binding and partitioning into detergent-insoluble mem-
branes and signal transduction, CT and LTIIb chimeric 
toxins were prepared. Analysis of these chimeric toxins 
confirmed that toxin-induced signal transduction de-
pended critically on the specificity of ganglioside struc-
ture. The mechanism(s) by which ganglioside GM1 
functions in signal transduction likely depends on cou-
pling CT with caveolae or caveolae-related membrane 
domains.
 
I
 
n
 
 polarized epithelial cells, signal transduction by chol-
era toxin (CT)
 
1
 
 and the structurally related 
 
Escheri-
chia coli
 
 heat-labile toxin type I (LTI) requires en-
docytosis of toxin–receptor complexes into the apical
endosome, retrograde transport into Golgi cisternae or
ER (Lencer et al., 1992, 1993, 1995
 
a
 
; Orlandi et al., 1993;
Majoul et al., 1996; Orlandi, 1997), and finally transport of
toxin across the cell to its site of action on the basolateral
membrane. In the human intestine, this process leads to
intestinal salt and water secretion and the massive diar-
rhea seen in cholera.
CT and LTI are composed of five identical B polypep-
tides that bind GM1 at the cell surface, and a single A
polypeptide. The A polypeptide is composed of two do-
mains (A
 
1
 
 and A
 
2
 
) linked by an exposed loop containing a
site for proteolytic cleavage and a disulfide bond that
bridges the cleavage site (Sixma et al., 1991; Spangler,
1992; Zhang et al., 1995). The pentameric B subunit (55
kD) binds specifically five GM1 molecules with high affin-
ity. Proteolytic cleavage within the exposed loop of the A
subunit and reduction generates the enzymatically active
A
 
1
 
 peptide (
 
z
 
22 kD), which enters the cell and activates
adenylyl cyclase by catalyzing the ADP-ribosylation of the
 
a
 
 subunit of the heterotrimeric GTPase Gs (for review see
Spangler, 1992). The A
 
2
 
 peptide (
 
z
 
5 kD) forms the scaf-
folding that tethers the A and B subunits together and
contains a COOH-terminal K(R)DEL motif. The KDEL-
motif protrudes from the pentameric B subunit on the side
that binds GM1 at the cell surface (Zhang et al., 1995).
Based on our published data, we have proposed that tar-
geting of toxin into the cell may plausibly depend on the
structure and function of the toxin’s endogenous receptor
ganglioside GM1 (Lencer et al., 1995
 
a
 
). For example, we
find that the endoplasmic reticulum targeting K(R)DEL
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motif on the toxin’s A subunit is not absolutely required
for toxin action (but in its absence, signal transduction is
significantly less efficient), and that purified CT B subunit,
in the absence of signals from A subunit, will also traverse
a transcytotic pathway. Thus, simply binding or clustering
GM1 by the toxin’s pentameric B subunit appears to be
sufficient for transport into all intracellular compartments
necessary for signal transduction. Whether GM1 provides
specific targeting information to this system (or whether
other glycosphingolipids could perform the same func-
tion), and if so, how such a glycolipid may act as a sorting
motif in vesicular transport, remains unknown.
In many cell types, a large fraction of GM1 clusters in
caveolae. In fact, cholera toxin has already been used to
identify caveolae in human A431 epidermoid cells, canine
MDCK epithelial cells, and endothelium of rat lung (Par-
ton, 1994; Parton et al., 1994; Schnitzer et al., 1995
 
b
 
). Ca-
veolae and related membrane structures display light den-
sity and resistance to detergent extraction by virtue of
their lipid and possibly protein composition (Anderson,
1993
 
a
 
; Schroeder et al., 1994; Simons and Ikonen, 1997).
These specialized membrane domains exist on both intra-
cellular (Brown and Rose, 1992) and plasma membranes
(Anderson, 1993
 
a
 
). Caveolae are thought to mediate key
cellular functions that include ligand-induced signal trans-
duction, protein and lipid sorting, endocytosis, and (in vas-
cular endothelium) transcytosis (van Meer and Palade,
1989; Simons and Wandinger-Ness, 1990; Anderson et al.,
1992; Dupree et al., 1993; van Meer, 1993; Lisanti et al.,
1994; Parton et al., 1994; Schnitzer et al., 1994, 1995
 
c
 
;
Rodgers and Rose, 1996; Liu et al., 1997). Whether caveo-
lae mediate toxin-induced signal transduction in human
intestine, however, remains unknown.
Our aim in the present study was to test whether toxin
action depends on binding or clustering GM1 specifically.
To address this hypothesis, we took advantage of a mem-
ber of the family of related type II heat-labile toxins pro-
duced by 
 
E. coli
 
. The structures of type II toxins are simi-
lar but not identical to CT or LTI (Guth et al., 1986;
Holmes et al., 1986; Chang et al., 1987; Fukuta et al., 1988).
The major structural differences are found in the penta-
meric B subunits, and this is reflected functionally in that
CT or LTI and type II toxins bind to different glycosphin-
golipids. In particular, the type II toxin LTIIb binds with
highest affinity to ganglioside GD1a and not at all to GM1
(Fukuta et al., 1988). The structure and function of the en-
zymatic A subunits of CT or LTI and LTIIb, however, are
homologous. They are ADP-ribosyltransferases with simi-
lar enzymatic activities in vitro (Chang et al., 1987; Lee et
al., 1991). Like CT, the A
 
2
 
 peptide of LTIIb also contains a
COOH-terminal KDEL-motif that protrudes from the B
pentamer in a position where the KDEL-sequence may
plausibly interact with membrane receptors (van den Ak-
ker et al., 1996).
The studies reported here show that signal transduction
by heat-labile enterotoxins in the model polarized intesti-
nal cell line T84 depends specifically on binding or cluster-
ing GM1. Binding to a closely related ganglioside, GD1a, ren-
ders  the toxin inactive. We also find that ganglioside
structure dictates toxin association with caveolae-like mem-
brane domains. Thus, the mechanism(s) by which ganglio-
side GM1 functions in signal transduction likely depends
 
on the ability of GM1 to couple cholera and related heat-
labile enterotoxins with caveolae or caveolae-related mem-
brane structures.
 
Materials and Methods
 
Materials, Toxins, and Antibodies
 
CT was obtained from Calbiochem (San Diego, CA), cholera toxin B sub-
unit–colloidal gold was from List Biological Laboratories (Campbell,
CA), and purified gangliosides GM1 and GD1a from Matreya, Inc.
(Pleasant Gap, PA). All other commercially available reagents were from
Sigma Chemical Co. (St. Louis, MO) unless otherwise stated.
Periplasmic extracts from recombinant 
 
E. coli
 
 containing CT and
LTIIb and purified LTIIb were prepared as previously described (Lencer
et al., 1995
 
a
 
). Where indicated, LTIIb (20 nM) was activated by preincu-
bation with 20 
 
m
 
g/ml trypsin
 
 
 
for 30 min at 30
 
8
 
C as described (Lencer et al.,
1997). Purified anthrax protective antigen was a gift from R.J. Collier
(Harvard Medical School). Purified mutant LT G33D B subunit was a gift
from T.R. Hirst (University of Bristol, Bristol, UK). Sulfo-NHS-biotin
(Pierce Chemical Co., Rockford, IL) was used to label purified CT and
LTIIb as previously described (Lencer et al., 1992). Antibodies used in-
cluded polyclonal rabbit antiserum against CT A and B subunits (Lencer
et al., 1995
 
b
 
) and LTIIb holotoxin (Connell and Holmes, 1992) and mono-
clonal antibodies raised against CT B and A subunits (Holmes and
Twiddy, 1983) and LTIIb B and A subunits (as described in Holmes and
Twiddy, 1983). Monoclonal antibody 11E5 is specific for the B subunit of
LtIIb, and 3C4 is specific for the A subunit of LTIIb. Neither 11E5 nor
3C4 cross-reacts with the A or B subunit of CT.
 
Cell Culture
 
T84 and Y1 cells obtained from American Type Culture Collection
(Rockville, MD) were cultured and passaged as previously described
(Lencer et al., 1995
 
a
 
). Cells from passages 70–98 (T84) and 41–70 (Y1)
were used for these experiments.
 
Preparation of Recombinant Wild-Type and Mutant CT 
and LTIIb Chimeric Toxins
 
All holotoxin-producing clones were made in the vector pBluescript
SKII
 
2
 
 (Stratagene, La Jolla, CA) and were expressed from the IPTG-
inducible 
 
lac
 
 promoter of the vector. Table I identifies the toxin constructs
used in this study. pMGJ148 encodes native CT holotoxin with the LTIIb-B
gene leader expressing CT B (Jobling et al., 1997), and pMGJ176 encodes
native LTIIb holotoxin. Chimeric holotoxin clones were made by recipro-
cal exchange of restriction fragments encoding the A
 
1
 
 polypeptide or A
 
2
 
and B polypeptides using the unique ClaI restriction site naturally present
in the DNA encoding the 11-residue loop between cys-187 of CT A
 
1
 
 and
cys-199 of CT A
 
2
 
. A ClaI restriction site was introduced into the DNA en-
coding the loop between cys-185 of LTIIb A
 
1
 
 and cys-197 of LTIIb A
 
2
 
 in
two steps. First, the LTIIb-A
 
1
 
 coding sequence was PCR-amplified from a
native LTIIb holotoxin clone (MGJ176) with oligonucleotides IIbA1RC
(5
 
9
 
GCCATCGATGCTTTATTATTTGGTAGACA3
 
9
 
) and M13 reverse
primer and cloned into SmaI-digested pUC18 to produce pMGJ182. Sec-
ond, the LTIIb-A
 
2
 
-B coding sequence was similarly amplified and cloned
using oligonucleotides IIb-A
 
2
 
 (5
 
9
 
CGGGCATCGATGGATACCTGTG-
CCTC3
 
9
 
) and M13-20 primer to produce pMGJ178. An XbaI-ClaI frag-
ment of pMGJ182 (LTIIb-A
 
1
 
) and a ClaI-SalI fragment of pMGJ178
(LTIIb-A
 
2
 
-B) were cloned into XbaI-SalI–digested pBluescript SKII
 
2
 
 to
create pMGJ183. This clone produced LTIIb-holotoxin with a single
amino acid substitution (S193M) in the A
 
1
 
-A
 
2
 
 loop encoded by the ClaI
site. A ClaI-KpnI fragment of pMGJ178 (LTIIb-A
 
2
 
-B) was cloned into a
ClaI-KpnI–cut pMGJ148 to create pMGJ179 encoding the CT-A
 
1
 
/LTIIb-
A
 
2
 
/LTIIb-B chimera. An NheI-ClaI fragment of pMGJ182 (LTIIb A
 
1
 
)
was cloned into XbaI-ClaI–cut pMGJ148 to create pMGJ184, encoding
the LTIIb-A
 
1
 
/CT-A
 
2
 
/CT-B chimera.
Plasmid pMGJ187 was created to produce an LTIIb
 
A
 
-CT
 
B
 
 chimera
with a fusion joint in the middle of the A
 
2
 
 domain so as to maximize the
homologous A
 
1
 
–A
 
2
 
 and A
 
2
 
–B domain interactions, predicted to enhance
holotoxin formation. The dibasic KR peptide at the fusion joint is con-
served between CT A
 
2
 
 and LTIIb A
 
2
 
 and is located at the point where
the A
 
2
 
 domain penetrates the B subunit in both toxins. A hybrid LTIIb
 
A2
 
-
CT
 
A2
 
 oligonucleotide IIBCTKR (KR coding sequence underlined; 
Wolf et al. 
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TTTAAGAAATATATAAAGAGACAAATATTTTCAGGC) was used
in conjunction with a CTB reverse primer (SP4, CTTGAAAAGTTGCA-
CCATTC) to PCR amplify the region encoding CT-A
 
2
 
-CT-B
 
 
 
from a clone
lacking T7 primer sequences. LTIIb-A
 
1
 
 sequences were added by using
the PCR product to prime on a IIb holotoxin clone and reamplifying with
a vector primer (T7; Stratagene) and SP4. The product was then digested
with AccI and cloned into pMGJ184, replacing the A
 
2
 
 encoding sequences.
For chimeric toxins 179 (pMGJ179) and 184 (pMGJ184), junctions of
the chimeric A subunits were made within the C-loop connecting the A
 
1
 
and A
 
2
 
 peptides. This preserved the complete A
 
2
 
 peptide, including the
KDEL-motif, and all interactions between the A
 
2
 
 peptide and its respec-
tive pentameric B subunit. For chimeric toxin 187 (pMGJ187), the junc-
tion of the chimeric A subunit was in the middle of the A
 
2
 
 domain,
thereby conserving the entire loop region between A
 
1
 
 and A
 
2
 
 from LTIIb.
 
Preparation of Toxin Extracts
 
500 ml Luria Broth cultures of 
 
E. coli
 
 TE1 bearing each of the plasmids in
Table I were grown at 37
 
8
 
C with 50 
 
m
 
g/ml each of ampicillin and methicil-
lin and induced overnight with 200 
 
m
 
M IPTG. Extracts were prepared es-
sentially according to French et al. (1996), except that cells were resus-
pended in 15 ml 20% sucrose, 0.2 M Tris, pH 7.5, 1 mM EDTA, 0.5 mg/ml
lysozyme, incubated for 15 min at ambient temperature followed by os-
motic shock with the addition of 15 ml cold sterile water, mixed, and incu-
bated 15 min on ice. The supernatant was cleared by centrifugation at
16,000 
 
g
 
 at 4
 
8
 
C and retained as crude toxin extract. Periplasmic extracts
were dialyzed overnight at 4
 
8
 
C against 1,000-vol excess HBSS (containing
in g/liter 0.185 CaCl
 
2
 
, 0.098 MgSO
 
4
 
, 0.4 KCl, 0.06 KH
 
2
 
PO
 
4
 
, 8 NaCl, 0.048
Na
 
2
 
HPO
 
4
 
, 1 glucose, to which 10 mM Hepes, pH 7.4, was added).
 
Electrophysiology, Mouse Y1 Adrenal Cell, and
Toxin-binding Assays
 
HBSS was used for all assays unless otherwise stated. An antibody-based
or ligand-binding ELISA was used to define binding isotherms of purified
CT and LTIIb, and biotin-labeled LTIIb was used to define binding speci-
ficity as previously described (Lencer et al., 1995
 
c
 
). For electrophysiologi-
cal studies on T84 cells, measurements of short circuit current (Isc) and re-
sistance (R) were performed with 0.33 cm
 
2
 
 monolayers as previously
described (Lencer et al., 1992).
Toxin action on mouse Y1 adrenal cells was assessed as a cAMP-
dependent shape change as described (Guth et al., 1986). Two methods
were used to calibrate toxin activity. First, 100-
 
m
 
l samples of serial twofold
dilutions in culture medium of periplasmic extracts containing toxins were
applied to 96-well plates of Y1 cells grown to confluence for 2 d. After
overnight incubation at 37
 
8
 
C, toxin-induced shape change was scored
based on the fraction of cells exhibiting rounding, as assessed by light mi-
croscopy. Scores from 0 to 4
 
1
 
 were assigned as follows: 4
 
1
 
 (75–100%
cells rounded), 3
 
1
 
 (50–75% cells rounded), 2
 
1
 
 (25–50% cells rounded),
1
 
1
 
 (
 
,
 
25% cells rounded), and 0 (no detectable cell rounding). The
amount of toxin present in the last dilution giving 4
 
1
 
 rounding was as-
signed a value of 1 unit (U). Toxin titers were calculated as (dilution fac-
tor) 
 
3 
 
10 U/ml original sample. In the second method, toxin titers were as-
sessed in a 3-h time course and graded against standard curves constructed
in parallel by serial dilutions of purified LTIIb (20–0.08 nM).
 
Detergent Extractions of Filter-grown Monolayers
 
T84 cells grown on 5-cm
 
2
 
 filters were incubated apically with 20 nM CT,
LTIIb, or no toxin in HBSS for 20–30 min at 4
 
8
 
C, washed to remove all
unbound toxin, immersed in 1.0 ml of ice-cold 1% TTBS (150 mM NaCl,
10 mM Tris, 1% Triton X-100, pH 7.5, 0.175 mM PMSF, and 20 
 
m
 
g/ml chy-
mostatin), and tumbled end over end for 30 min at 4
 
8
 
C. Triton-soluble
proteins were removed and saved. Triton-insoluble proteins were solubi-
lized in 1% TTBS containing 1% 
 
N
 
-octylglucoside at 4
 
8
 
C. Acetone pre-
cipitates of solubilized proteins were recovered by centrifugation at
15,000–20,000 
 
g
 
 for 15 min and analyzed by SDS-PAGE and Western
blotting (Lencer et al., 1995
 
b
 
).
 
Sucrose Equilibrium Density Centrifugation
 
One or two confluent monolayers of T84 (45 cm
 
2
 
 each) or a 150-cm
 
2
 
 flask
of confluent Y1 cells was used for isolation of detergent-insoluble mem-
branes. All steps were performed at 4
 
8
 
C. Cells were scraped into 2 ml of
ice-cold 1% TTBS and homogenized with five strokes in a tight-fitting
Dounce homogenizer on ice. The homogenate was adjusted to 40% su-
crose by addition of 2 ml of 80% sucrose in 1% TTBS, layered under a lin-
ear 5–30% sucrose gradient, and centrifuged at 39,000 rpm for 16–20 h in a
swinging bucket rotor (model SW41; Beckman Instruments, Palo Alto,
CA). The presence of a floating membrane fraction was noted visually.
Sequential 0.5- or 1-ml fractions were collected from the top of the gradi-
ent. 20 
 
m
 
l from each fraction was analyzed by SDS-PAGE and Coomassie
stain or Western/ligand blot. Sucrose density was monitored by refractom-
etry. Light scattering was measured as absorbance at 600 nm (Spectra
Max; Molecular Dynamics, Sunnyvale, CA).
 
Ganglioside Extraction and Analysis
 
Ganglioside-enriched lipid extracts and ligand blots using LTIIb and CT
were prepared as modified from described methods (Fukuta et al., 1988;
Schnaar and Needham, 1994). Total lipids were extracted from 1,500–
4,500 cm
 
2
 
 confluent T84 monolayers in chloroform/methanol/water (10:10:1)
in a total volume of 10 ml. For quantitative thin layer chromatography,
phospholipids and cholesterol were removed on silica gel. Thereafter, the
glycosphingolipids were separated by ion exchange chromatography, and
the gangliosides were eluted in a monosialoganglioside fraction and poly-
sialoganglioside fraction. The fractions were separated on HPTLC plates
(Silica Gel 60; E. Merck, Darmstadt, Federal Republic of Germany), and
the gangliotetrose series (GM1, GD1a, GD1b, and GT1b) was detected by
ligand blotting with CT B subunit (1 nM) and anti–CT B subunit antibod-
ies in an ELISA performed on the HPTLC plate. Values are presented as
total mass gangliosides (pmol) per mg cell protein. For “dot blots” and for
qualitative thin layer chromatography, the concentrated total lipid ex-
tracts were enriched for gangliosides by Folch cut in chloroform/metha-
nol/water (10:10:1). 100 ng each of ganglioside GM1 and GD1a and 10–15
 
m
 
l representing 20–30% of total T84 cell ganglioside-enriched lipid ex-
tracts were applied to HPTLC strips or HPTLC plates and analyzed as de-
Table I. Construction of Recombinant Wild-Type and Chimeric Toxins
Clone Toxin or chimera A1 subunit Junction A2 subunit B subunit
pMGJ148 CT (native) CTA1 CGNAP SSMSNTC CTA2-CTB
187 199
pMGJ179 CTA/LTIIbB CTA1 CGNAP SSMDTTC LTIIbA2-LTIIbB
187 197
pMGJ183 LTIIb(S193M) LTIIbA1 CLPNN ASMDTTC LTIIbA2-LTIIbB
185 197
pMGJ184 LTIIbA/CTB LTIIbA1 CLPNN ASMSNTC CTA2-CTB
185 199
pMGJ187 LTIIbA/CTB LTIIbA1 KKYIKRQIFF LTIIbA2::CTA2-CTB
213 224
Amino acid sequences of the junctions formed between A1 and A2 peptides are shown in letter code. Numbers beneath cysteines indicate the position in the native protein. In the
native protein these cysteines are linked by disulfhydryl bond. *above the letter codes identifies the serine-protease cleavage site linking the A1 and A2 peptides. The cleavage site
for pMGJ187 is the same as for native LTIIb and the fusion joint (underlined) is within the A2 domain instead of between the A1 and A2 domains.
R *
R *
* K
* KThe Journal of Cell Biology, Volume 141, 1998 920
scribed (Fukuta et al., 1988). For dot blots, GM1 and GD1a were detected
by ligand blotting with CT (1 nM) and LTIIb (1 nM) and anti-CT or LTIIb
antibodies in an ELISA performed on the HPTLC plate.
Statistics
Data were analyzed using Statview 5121 software (Brainpower, Inc., Cal-
abasas, CA).
Results
We used CT and the type II heat-labile toxin from E. coli
LTIIb to test the hypothesis that GM1 provides specificity
to toxin action. LTIIb and CT are structurally and func-
tionally homologous. LTIIb, however, binds GD1a and
displays no detectable binding to GM1 (Fukuta et al.,
1988; Lee et al., 1991).
CT and LTIIb Bind Specifically to T84 Cell
Apical Membranes
Initial experiments showed that both CT and LTIIb bound
to receptors on T84 cells with high affinity (2–5 nM) (Fig. 1
A). Competition experiments showed that receptor bind-
ing was specific (Fig. 1 B). Competition with LTIIb (1 mM)
inhibited by 70% the binding of biotin-labeled LTIIb to
T84 cell membranes. Binding was not inhibited, however,
by competition with anthrax protective antigen (200 nM),
chicken IgY (1 mM), bovine serum albumin (5 mg/ml), or
rLTI B subunit(G33D) (500 nM). Similarly for CT, com-
petition with rCT B subunit inhibited CT binding by 93%.
To demonstrate that T84 cells express GD1a and GM1,
ganglioside-enriched lipid extracts of confluent monolay-
ers of T84 cells (1,500–4,500 cm2) were prepared and dot-
ted onto HPTLC strips, dried, blocked for nonspecific
binding, and assessed for the presence of GM1 and GD1a
by ligand affinity-blot using purified CT (20 nM) or
rLTIIb (20 nM). Purified GM1 and GD1a were used as
standards (300 ng each). Fig. 2 A shows that T84 cells ex-
press lipids to which both CT and LTIIb bind specifically.
Anthrax toxin protective antigen (12 nM) did not label the
lipid dot blots. Neither CT nor LTIIb bound proteins of
total T84 cell extracts (50–100 mg) as assessed by SDS-
PAGE and ligand blot (not shown). Analysis of glycolipid
composition by thin layer chromatography confirmed the
presence of GM1 and GD1a in polarized T84 cell mem-
branes (Fig. 2 B). T84 cells contained per microgram total
Figure 1. CT and LTIIb bind
specifically with high affinity
to intact T84 monolayers. All
binding assays were per-
formed in HBSS containing
5% bovine serum albumin.
Nonspecific signals in the ab-
sence of applied toxins were
nearly identical to back-
ground (0.09 O.D. units). (A)
Binding isotherms for CT
and LTIIb applied at 48C to
T84 cells grown on plastic.
Polyclonal anti-CT or anti-
LTIIb antibodies were used
to detect toxin bound at the
cell surface. (B) Steady-state
binding of biotin-labeled
LTIIb (5 nM) or CT (5 nM)
to T84 cells at 48C in the
presence of excess unlabeled LTIIb (1 mM), LTG33D B subunit (500 nM), purified anthrax protective antigen (200 nM), chicken IgY (1
mM), or unlabeled CT (1 mM) as indicated. Biotin-labeled toxins are indicated by *. In these studies, enzyme-linked avidin was used to
detect toxin bound at the cell surface.
Figure 2. Ganglioside-
enriched lipid extracts of T84
cell monolayers contain both
GM1 and GD1a. (A) Lipid
extracts prepared from 1,500
cm2 confluent T84 cells (third
lane) and purified GM1 (first
lane) and GD1a (second lane)
standards (300 ng each)
were applied to activated sil-
ica gel plates, processed as
described in Materials and
Methods, and ligand blotted
with CT (1 nM, top) or LTIIb
(1 nM, bottom). Toxin bind-
ing to ganglioside extracts
was assessed by application
of specific antitoxin antibod-
ies, followed by HRP-conju-
gated secondary antibody,
and development using en-
hanced chemiluminescence.
(B) Size resolution of T84
cell gangliosides by thin layer
chromatography and resor-
cinol spray. GM1 standard
(first lane), GD1a standard (second lane), T84 cell (4,500 cm2)
lipid extract lower phase Folch cut (third lane), and upper phase
Folch cut (fourth lane). In this preparation, the bulk of acidic gly-
colipids including GD1a remained associated with the lower lipid
soluble phase because of conditions of Folch extraction (low salt
and pH). Gangliosides migrating with GD1a are apparent in the
third lane (and faintly in the fourth). Gangliosides migrating with
GM1 are apparent in the fourth lane.Wolf et al. Sorting of Cholera Toxin by Ganglioside GM1 921
protein 0.82 pmol GM1, 2.41 pmol GD1a, 0.38 pmol
GD1b, and 2.7 pmol GT1b (data from Pam Fredman and
Jan Holmgren, University of Göteborg, Sweden). Thus,
T84 cells express specific high-affinity receptors for LTIIb
and CT, which represent ganglioside GD1a and GM1, re-
spectively.
Toxin Binding to GM1 but Not GD1a Leads to a 
Physiological Response
We next examined the ability of CT and LTIIb to elicit
cAMP-dependent Cl2 secretion. Fig. 3 A shows the time
course of Cl2 secretion elicited by CT (20 nM) or LTIIb
(20 nM) applied to apical reservoirs of T84 cell monolay-
ers. After a characteristic “lag” phase, CT elicited a brisk
secretory response. LTIIb, however, was inactive. The ad-
dition of vasoactive intestinal peptide (VIP, 3 nM) to baso-
lateral reservoirs at 125 min elicited a rapid response,
demonstrating the viability of these monolayers. The in-
ability of LTIIb to elicit a response from T84 cells was not
dose dependent, as 500 nM LTIIb was still inactive. (A
small signal, Isc 5 4.8 mA/cm2 was obtained at 10 mM
LTIIb, n 5 2.) Structural differences between CT and
LTIIb in the C-loop connecting the A1 and A2 peptides did
not explain these results since proteolytic activation of the
LTIIb A subunit by trypsin pretreatment in vitro had no
effect on signal transduction by LTIIb (n 5 2). LTIIb was
also not active when applied to basolateral membranes of
T84 cells, indicating that toxin function did not depend on
cell polarity (data not shown). To demonstrate that LTIIb
was nonetheless as equally functional as an ADP-ribosyl
transferase, we applied both CT and LTIIb to mouse Y1
adrenal cells. Y1 adrenal cells respond to cAMP-agonists,
including both CT and LTIIb with a characteristic shape
change (Fig. 3, B–E). In this assay, LTIIb displayed
greater potency than CT (toxic dose 10 vs. 300 pg/well,
LTIIb vs. CT).
Data from 12 independent experiments on T84 cells are
summarized in Table II. The results of these studies show
that high-affinity binding of LTIIb to the cell surface of
T84 cells is not sufficient for signal transduction. These re-
sults provide evidence that signal transduction by CT in
T84 cells depends on toxin binding or clustering GM1 spe-
cifically—a function of the toxin’s B subunit.
Functional Association of Ganglioside GM1 with 
Detergent-insoluble Membrane Domains
The requirement for binding GM1 specifically in toxin ac-
tion implies that GM1 can distinguish between membrane
components in T84 cells that function in toxin-induced sig-
nal transduction. Based on available evidence, the mem-
brane structures recognized by GM1 (or clusters of GM1)
and likely to subserve such a function are caveolae or “ca-
veolae-like” detergent-insoluble membrane domains (Par-
ton, 1994; Parton and Simons, 1995; Schnitzer et al., 1995b,
1996). Thus, to test whether CT and LTIIb may partition
differentially into caveolae-like membranes, we examined
the detergent-solubility of CT–GM1 and LTIIb–GD1a
complexes in T84 cells.
Initial studies showed that the CT–GM1 complex frac-
tionated with Triton-insoluble membrane fractions iso-
lated from T84 cell monolayers at 48C (Fig. 4, A and B).
These membrane fractions were enriched .100-fold in a
subset of cellular proteins that included CD73 (the GPI-
linked 59-ectonucleotidase) and caveolin 1 (Strohmeier et al.,
1997) but were depleted in B1 integrins and the Na1 K1
2Cl2 cotransporter (data not shown). The interactions be-
tween CT–GM1 and Triton-insoluble membranes were
stable and resisted six successive rounds of extraction in
detergent (as assessed biochemically). While some vari-
ability was observed in the fraction of CT–GM1 solubi-
lized by 1% Triton X-100, CT–GM1 always fractionated
Figure 3. Signal transduction by
CT and LTIIb in polarized human
intestinal T84 monolayers and
mouse Y1 adrenal cells. (A) Time
course of Cl2 secretion induced by
application of CT (20 nM) or
LTIIb (20 nM) to apical reservoirs
of T84 cell monolayers. The via-
bility of monolayers exposed to
LTIIb was demonstrated by appli-
cation of the cAMP-agonist VIP
to basolateral reservoirs at 120
min. (B–E) Bright field micro-
graphs of mouse Y1 adrenal cells
treated for 180 min at 378C with
the cAMP-agonist forskolin (10
mM,  C), CT (20 nM, D), LTIIb (20
nM, E), or buffer alone (B).
Table II. Effect of CT vs. LTIIb on cAMP-dependent Cl2 
Secretion in Human Intestinal T84 Cells
Purified native toxin LAG dlsc/dt Peak Isc
min mA/cm/min mA/cm2
CT 20 nM 26 6 1.3 1.2 6 0.2 59 6 5
n 5 9
LTIIb 20 nM .128* Not Present 3.9 6 0.2*
n 5 12
Values are means 6 SE. *Peak Isc was obtained at 120 min. ANOVA, P 5 0.0001.The Journal of Cell Biology, Volume 141, 1998 922
with detergent-insoluble membranes. In six of nine stud-
ies, the overwhelming mass of CT–GM1 fractionated with
these membranes (as in Fig. 4 A). In contrast, nearly all of
the LTIIb–GD1a complex was solubilized by 1% Triton
X-100, and both A and B subunits of LTIIb were found at
the bottom of the gradient with all other solubilized pro-
teins (Fig. 4 B, n 5 9). In some studies (especially when
concentrations .50 nM were used), a small amount of
LTIIb could be detected in detergent-insoluble light-den-
sity membrane fractions (estimated ,1–2%). In all studies
on T84 cells, the differential association of LTIIb and CT
with Triton-insoluble membranes was readily apparent.
As CT elicited a physiological response from T84 cells
but LTIIb did not, these data raised the distinct possibility
that toxin association with detergent-insoluble membranes
may be required for signal transduction. To test this idea,
mouse Y1 adrenal cells were examined. As defined above,
both CT and LTIIb elicit a cAMP-dependent shape
change in this cell type, and LTIIb is more potent than CT.
Thus, if toxin action depends on association with deter-
gent-insoluble membranes, studies on Y1 cells should
show that both CT–GM1 and LTIIb–GD1a fractionate
with membranes that float up into the sucrose gradient af-
ter detergent extraction. These studies showed the pre-
dicted results. In Y1 cells, both CT–GM1 and LTIIb–
GD1a complexes fractionated with detergent-insoluble
membranes (Fig. 4 C, n 5 2). Thus, in human T84 and
mouse Y1 cells, the ability of each toxin to associate with
this specialized membrane fraction correlated with the
ability of each toxin to elicit a cAMP-dependent intracel-
lular signal.
LTIIb-CT Chimeric Toxins
To verify this idea, recombinant chimeric toxins were pre-
pared by combining the enzymatic A1 domains of CT with
the A2 domains and B subunit of LTIIb, and vice versa
(Table I). In doing so, LTIIb A subunits with CT A2 do-
mains were targeted into the cell by CT B subunits, which
bind GM1 (chimeras 187 and 184, termed LTIIbA/CTB),
and CT A subunits with LTIIb A2 domains were targeted
into the cell by LTIIb B subunits, which bind GD1a (chi-
mera 179, termed CTA/LTIIbB). Recombinant LTIIb
S193M (see Materials and Methods) was used to construct
the chimeric toxins described above, and this toxin pre-
dicted to exhibit wild-type phenotype was also prepared.
Trypsin-cleavage sites between A1 and A2 domains were
present in all of the chimeric toxins. The chimeras 184 and
187 containing alternative fusion sites within the A
polypeptide were generated to test for possible effects of
the fusion joint location on A and B subunit assembly and
function. Western blots of each preparation confirmed the
predicted structures of the chimeric toxins (data not shown).
The function of each recombinant toxin in periplasmic
extracts prepared from E. coli TE1 was examined by ap-
plying samples of the extracts to apical membranes of po-
Figure 4. Association of the CT–GM1 and
LTIIb–GD1a complexes with detergent-
insoluble apical membrane domains in hu-
man T84 and mouse Y1 cells. Polarized
human intestinal T84 or nonpolarized
mouse Y1 adrenal cell monolayers were
exposed apically to CT (20 nM) or LTIIb
(20 nM) at 48C for 30 min, and unbound
toxins were removed by washing. The
monolayers were homogenized in 1%
TTBS at 48C, adjusted to 40% sucrose,
and layered under a 5–30% continuous su-
crose gradient as described in Materials
and Methods. Fractions from left to right
(top to bottom) represent linear sucrose
gradient from 5–32% sucrose. (A) SDS-
PAGE and Coomassie stain (top) and
Western blot (bottom) of sucrose gradient
fractions from T84 cells. Fractions 2–15
represent linear sucrose gradient from
5–32% sucrose. Less than 1% total cellu-
lar protein floats into the gradient (frac-
tions 6–9, representing 18.2–22.8% sucrose).
This fraction is highly enriched for the
CT–GM1 complex as assessed by Western
blot. Fractions 16–19 represent Triton-sol-
uble proteins at 40% sucrose. (B) Sucrose
gradient of T84 cells exposed apically to
biotin-labeled CT or LTIIb as described
above and analyzed for CT or LTIIb B
subunits by avidin blot. For gradients la-
beled CT and LTIIb, fractions 10 and 11 represent 19.4 –21% sucrose. Fractions 18–25 represent solubilized proteins at 40% sucrose.
(C) Sucrose gradient of Y1 cells exposed to CT or LTIIb as described above and analyzed for CT or LTIIb A subunits by Western blot.
For CT, fractions 11–13 represent 19.5–23.9% sucrose. For LTIIb, fractions 9–11 represent 19–24% sucrose. In both gradients, fractions
18–25 represent solubilized proteins at 40% sucrose. Lanes C indicate 1 ng of purified toxins run as controls. In all studies, A and B sub-
units for CT and LTIIb fractionated together.Wolf et al. Sorting of Cholera Toxin by Ganglioside GM1 923
larized human intestinal T84 cell monolayers or to mouse
Y1 adrenal cells. Preparations of all wild-type and chi-
meric toxins elicited a potent cAMP-dependent shape
change from mouse Y1 adrenal cells, demonstrating that
all toxins were functional. Thus, in Y1 cells, toxin binding
to either GM1 or GD1a led to cAMP-dependent shape
change. In contrast, signal transduction by chimeric toxins
applied to T84 cells was dependent on toxin binding to
GM1 specifically.
Chimeric Toxins That Enter the Cell via Binding or 
Clustering GM1
Fig. 5 A shows that wild-type LTIIb and LTIIb S193M tox-
ins, which bind GD1a (5,000 U/ml), were inactive when
applied to apical membranes of T84 monolayers (as ex-
pected). The chimeric toxin 184 (LTIIbA/CTB, 5,000 U/ml),
however, which was predicted to enter the cell via binding
GM1, elicited a distinct Cl2 secretory response. Nearly
identical results were obtained with chimeric toxin 187
(also LTIIbA/CTB, 5,000 U/ml), indicating that the failure
of wild-type LTIIb to elicit a secretory response in T84
cells cannot be due solely to the structure of the peptide
loop between C185 to C197 that joins the A1 and A2 do-
mains of LTIIb. We also found that currents induced by
LTIIbA/CTB chimeric toxins were not as great as those in-
duced by wild-type (wt) CT, suggesting that CT and LTIIb
A subunits may display differential potencies for intact hu-
man T84 cells. These data are summarized in Fig. 6 A.
To show that the Cl2 secretory response induced by chi-
meric toxin 184 (LTIIbA/CTB) was dependent on the spec-
ificity of B subunit binding to GM1, we examined the time
course of toxin action in the presence or absence of excess
soluble GM1 or GD1a as competitive and specific inhibi-
tors of B subunit function. Fig. 5 B shows that preincuba-
tion with 10 mM GM1 blocked completely the secretory
response elicited by chimera 184 (LTIIbA/CTB, 5,000 U/ml).
Preincubation with GD1a (10 mM), however, had no effect.
Furthermore, competition with rCT B subunit to block
binding of holotoxin also inhibited (dose dependently) the
Cl2 secretory response induced by chimera 184 (LTIIbA/
CTB). Competition with 10 mM LTIIb had no inhibitory
effect, but these studies (though still interpretable) were
confounded by a small secretory response induced by
LTIIb at this high dose (4.8 mA/cm2, n 5 2). These data
(summarized in Fig. 6 A) show that the secretory response
elicited by chimera 184 (LTIIbA/CTB) was dependent on
binding GM1, a function of its chimeric B subunit.
Chimeric Toxins That Enter the Cell via Binding or 
Clustering GD1a
Fig. 5 C shows the secretory response elicited by the com-
plementary chimeric toxin 179 (CTA/LTIIbB). While re-
combinant wild-type CT elicited a strong secretory re-
sponse (as expected), toxin-induced Cl2 secretion was
greatly attenuated when the CT A subunit was forced to
enter the cell via binding GD1a (data summarized in Fig. 6
B). In two of three independent preparations, periplasmic
extracts containing chimeric toxin 179 were completely in-
active on T84 cells, even though the chimeric toxin elicited
a potent cAMP-dependent response from Y1 cells (5,000
U/ml). In all studies, periplasmic extracts from E. coli TE1
not harboring toxin-producing plasmids were physiologi-
cally inactive when applied to either cell type (human T84
or mouse Y1, data not shown). Thus, to show that the ac-
tion of chimeric toxin 179 (CTA/LTIIbB) on Y1 cells was
dependent on the specificity of B subunit binding to GD1a
(as predicted), we examined the cAMP-dependent shape
change induced by chimeric toxin 179 in the presence or
absence of excess soluble GM1 or GD1a as competitive
Figure 5. Time course of CT and LTIIb chimeric toxins on
cAMP-dependent Cl2 secretion in polarized T84 monolayers.
(A) Time courses of Cl2 secretion (Isc) induced by application of
purified LTIIb, LTIIb(S193M), or chimeric toxin 184 (LTIIbA/
CTB) to apical reservoirs of T84 cell monolayers. (B) Time
courses of Cl2 secretion induced by application of chimeric toxin
184 (LTIIbA/CTB) to apical reservoirs of T84 cell monolayers
in the absence or presence of purified GM1 (10 mM) or GD1a
(10 mM) as competitive inhibitors. (C) Time courses of Cl2 secre-
tion induced by application of rCT, or chimeric toxin 179 (CTA/
LTIIbB) to apical reservoirs of T84 cell monolayers. All toxins
were applied in equivalent concentrations of 5,000 U/ml as as-
sessed by bioassay on Y1 cells.The Journal of Cell Biology, Volume 141, 1998 924
and specific inhibitors of B subunit function. Both wt rCT
and chimeric toxin 179 (CTA/LTIIbB) (5,000 U/ml) elicited
maximal cell rounding (75–100% cells rounded) after in-
cubation at 378C for 100 min. Preincubation with 10 mM
GD1a almost completely inhibited the cell rounding re-
sponse to chimera 179 (0–25% cells rounded at 100 min,
n 5 2 in quadruplicate). In contrast, preincubation with
10 mM GM1 had no effect (75–100% cells rounded at 100
min). The converse was found for wt rCT. As expected,
preincubation with GM1 (10 mM) inhibited the shape
change induced by rCT, but preincubation with GD1a
(10 mM) had no effect.
In parallel experiments, signal transduction by wt LTIIb
and chimeric toxin 184 (LTIIbA/CTB) was also examined
in mouse Y1 cells. GM1 (10 mM) completely inhibited the
response of Y1 cells to chimeric toxin 184 (LTIIbA/CTB)
(0–25% rounded cells at 140 min, n 5 2 in quadruplicate),
but GD1a (10 mM) had no effect (75–100% cells rounded
at 140 min). Likewise, GD1a inhibited the response to wt
LTIIb (25–50% rounded cells at 140 min, n 5 2 in quadru-
plicate), but GM1 had no effect (75–100% cells rounded at
140 min). Thus, signal transduction by chimeric toxin 184
and wt LTIIb in Y1 cells was also dependent on the speci-
ficity of ganglioside binding.
Taken together, these studies show that LTIIb A sub-
units were rendered functional in T84 cells by targeting
them into T84 cells via binding GM1 (chimeric toxins 184
and 187, LTIIbA/CTB), and conversely, CT A subunits
were rendered inactive by targeting them into the cell by
binding GD1a (chimeric toxin 179, CTA/LTIIbB) (summa-
rized in Fig. 6, A and B). Thus, the cAMP-dependent re-
sponses elicited by both chimeric toxins 179 (CTA/LTIIbB)
and 184 (LTIIbA/CTB) in mouse Y1 or human T84 cells
were dependent on binding GD1a or GM1, respectively,
functions of their chimeric B subunits.
Ganglioside Structure Dictates Association with 
Caveolae-like Membrane Domains
To strengthen the correlation between toxin-induced sig-
nal transduction and association with caveolae-like deter-
gent-insoluble membranes, chimeric toxins 184 (LTIIbA/
CTB) and 179 (CTA/LTIIbB) bound to apical receptors on
T84 cell monolayers were solubilized in Triton X-100 and
fractionated on sucrose gradients. Fig. 7 shows that chi-
meric toxin 184 (LTIIbA/CTB) floated into the sucrose gra-
dient as predicted. In contrast, the complementary chi-
meric toxin 179 (CTA/LTIIbB) was completely solubilized
and remained at the bottom of the gradient (n 5 2). Thus,
in T84 cells, binding (or clustering) GM1 dictates both
toxin association with detergent-insoluble membrane do-
mains and toxin-induced signal transduction.
Discussion
Functional Specificity of GM1 in CT-induced
Signal Transduction
The results of these studies show that specific functional
properties of GM1 that are not shared by GD1a are essen-
tial for cholera toxin action in human intestinal T84 cells.
Ganglioside function was assessed using two related en-
terotoxins, CT and LTIIb. These toxins distinguish be-
tween gangliosides GM1 and GD1a at the cell surface by
virtue of their dissimilar receptor binding B subunits.
Their enzymatically active A subunits, however, are ho-
mologous in structure and function. Both toxins activate
adenylyl cyclase inside the cell via the same mechanism of
action: ADP-ribosylation of the heterotrimeric GTPase
Gsa. Our data show that signal transduction by CT and
LTIIb depends on the specificity of receptor binding, a
function of the toxin’s B subunit.
Figure 6. Effect of CT and
LTIIb chimeric toxins on
cAMP-dependent Cl2 secre-
tion in polarized T84 mono-
layers. (A) DIsc (peak Isc
mean  6 SEM, 120 min after
toxin addition corrected for
baseline currents) for wt
LTIIb(S193M), chimeric toxin
187, or chimeric toxin 184
(LTIIbA/CTB) applied to api-
cal reservoirs of T84 cell
monolayers in the presence
or absence of purified GM1,
GD1a, rCT B subunit, and
rLTIIB as competitive inhib-
itors. ANOVA, P 5 0.0001.
* indicates conditions signifi-
cantly different from chimera
184 alone (third column) at
P  #  0.05 by multiple compar-
ison procedures. (B) DIsc
(peak Isc mean 6 SEM, 120 min after toxin addition corrected for baseline currents) for wt rCT and chimeric toxin 179 (CTA/LTIIbB) to
apical reservoirs of T84 cell monolayers in the presence or absence of GM1 or rCT B subunit as competitive inhibitors. ANOVA, P 5
0.0001. * indicates conditions significantly different from rCT alone (third column) at P # 0.05 by multiple comparison procedures. In all
studies, mean 6 SEM baseline currents were 1.1 6 0.2 mA/cm2, n 5 25.Wolf et al. Sorting of Cholera Toxin by Ganglioside GM1 925
Two lines of evidence support this view. First, CT and
type I E. coli heat-labile toxin LTI bound GM1 in T84 cells
and induced a physiological cAMP-dependent Cl2 secre-
tory response (this study and Lencer et al., 1995a, 1997).
Unlike CT and LTI, however, type II E. coli heat-labile
toxin LTIIb displayed no detectable binding to GM1, and
LTIIb did not elicit a physiological response in T84 cells.
Even so, LTIIb bound with high affinity to GD1a on hu-
man T84 cells, and the enzymatic A subunit of LTIIb was
capable of activating adenylyl cyclase, as evidenced by the
cAMP-dependent shape change elicited by LTIIb in cul-
tured mouse Y1 adrenal cells. That toxin action depended
critically on the specificity of ganglioside binding (a func-
tion of the B subunit) was confirmed by using recombinant
CT and LTIIb chimeric toxins. Thus, LTIIb A subunits
were rendered functional in T84 cells by targeting the A
subunit into the cell via binding GM1 (chimeric toxin LTI-
IbA/CTB), and conversely the function of CT A subunits
were rendered inactive by targeting the A subunit into the
cell by binding GD1a (chimeric toxin CTA/LTIIbB).
Toxin Action Depends on Association with
Detergent-insoluble Membrane Domains
We also find that the structure of the ganglioside receptor
determines association of toxin with caveolae-like deter-
gent-insoluble membrane domains. This was closely corre-
lated with toxin function as assessed by the activities of wt
CT, LTIIb, and chimeric toxins CTA/LTIIbB and LTIIbA/
CTB on human intestinal T84 and mouse Y1 adrenal cells.
That partitioning into detergent-insoluble membranes in
T84 cells depended critically on the specificity of ganglio-
side binding was confirmed by using recombinant CT and
LTIIb chimeric toxins as described above. Thus, in human
intestinal T84 cells, binding or clustering GM1, a function
of the B subunit, directs CT into a specialized detergent-
insoluble membrane fraction. In this respect, GM1 acts as
a sorting motif. As glycosphingolipids such as GM1 are lu-
minally oriented and cannot span the membrane bilayer to
interact with cytoplasmic proteins, these data imply that
the functional membrane receptor for CT and LT must in-
volve a membrane structure of greater complexity than
ganglioside GM1 alone.
Based on current evidence, we believe the membrane
structure(s) most likely to subserve such a sorting function
are caveolae or “caveolae-like” detergent-insoluble mem-
branes (Parton et al., 1995; Schnitzer et al., 1996; and this
study). The fact that GM1 represents a structural compo-
nent of caveolae in many other cell types (Parton, 1994;
Parton et al., 1994; Schnitzer et al., 1995b) provides evi-
dence in support of this hypothesis. Furthermore, that gly-
cosphingolipids can self-assemble with other similarly pre-
disposed cellular components is well described (Sharom
and Grant, 1978; Hakomori, 1983; Thompson and Tillack,
1985; Simons and van Meer, 1988; van Meer et al., 1989;
van Genderen and van Meer, 1993; van Meer, 1993). Such
a propensity for self-assembly may contribute to the driv-
ing force for lipid sorting and caveolae biogenesis in many
if not all cell types (Bretscher and Munro, 1993; Schroeder
et al., 1994; Thomas et al., 1994; Gorodinsky and Harris,
1995; Hanada et al., 1995). On the other hand, detergent-
insoluble membranes from T84 cells exclude GD1a in
preference to GM1, but detergent-insoluble membranes
from Y1 cells do not. These data provide evidence that
membrane components other than gangliosides contribute
to caveolae biogenesis, structure, and function, and this
likely varies among differentiated cell types and/or species
as previously suggested (Stan et al., 1997).
How specific gangliosides may function as discrete sort-
ing motifs for partitioning ligands into membrane subdo-
mains, however, remains undefined. The structures of
GM1 and GD1a differ most significantly in their respec-
tive carbohydrate head groups, and even these are closely
related (Hakomori, 1983). Nonetheless, detergent-insolu-
ble membrane microdomains of human intestinal T84 cells
clearly distinguish between these similar glycolipids. Thus,
one possibility is that carbohydrate head groups may de-
fine specificity in this system. If so, the results of these
studies would imply that epitopes on proteins or lipids res-
ident in the exoplasmic bilayer leaflet provide motifs for
sorting of membrane components at the cell surface and
possibly within endosomes and other transport vesicles (as
previously hypothesized; Fiedler et al., 1994; Simons and
Ikonen, 1997). Alternatively, glycosphingolipids exhibit
heterogeneity in structure of their lipid tails (Hakomori,
1983), and this may also impart specificity to glycolipid
function (Sandvig et al., 1994; Mayor and Maxfield, 1995).
When tested experimentally, replacing the ceramide moi-
ety on GM1 with aliphatic amines, cholesterol, or phos-
pholipid enhanced or reduced CT-induced signal trans-
duction in rat glioma C6 cells (Pacuszka et al., 1991).
Mechanism of Action: Signal Transduction by CT in 
Human Intestinal T84 Cells
Taken together, the results of these studies show that hu-
man intestinal T84 cells discriminate between toxin bound
to GM1 and GD1a by sorting GM1–toxin complexes into
caveolae-like detergent-insoluble plasma membrane sub-
domains. This appears to be critical for toxin function.
Based on available data, we can envision two plausible
consequences of such sorting on the mechanism of toxin-
induced signal transduction.
First, by analogy with the biology of GPI-linked (Roth-
berg et al., 1990; Anderson, 1993b; Deckert et al., 1996) and
dual-acylated proteins (Shenoy-Scaria et al., 1994; Bhatna-
gar and Gordon, 1997; Rehm and Ploegh, 1997), CT may
Figure 7. Association of chimeric toxins 184 LTIIbA/CTB (A) and
179 CTA/LTIIbB (B) with detergent-insoluble apical membrane
domains in human T84 cells. Sucrose gradient of T84 cells ex-
posed apically to chimeric toxins 184 and 179 and analyzed for
CT or LTIIb B subunits by Western blot. For gradient labeled
chimera 184, fractions 13–16 represent 19.2–24.8% sucrose. Frac-
tions 20–25 represent solubilized proteins at 40% sucrose. For
gradient labeled chimera 179, fractions 12–16 represent 19–28%
sucrose. Fractions 20–25 represent solubilized proteins at 40% su-
crose. Association of toxin with detergent-insoluble membranes
depends on binding GM1—a function of the toxin’s B subunit.The Journal of Cell Biology, Volume 141, 1998 926
ensure its own delivery to its target enzyme adenylyl cy-
clase by binding GM1 and thus partitioning itself into ca-
veolae-like membrane structures that also cluster Gsa and
adenylyl cyclase into a functional unit (Huang et al., 1997).
Alternatively, as signal transduction by CT in polarized
cells requires endocytosis and transport of toxin through
multiple intracellular compartments (Lencer et al., 1992,
1993, 1995a,b; Orlandi et al., 1993; Majoul et al., 1996; Or-
landi, 1997), the results of these studies raise the possibil-
ity that GM1 may sort CT into caveolae or caveolae-like
membrane structures, which then mediate endocytosis of
toxin-receptor complexes. If so, this would fit nicely with
morphological evidence that CT enters hepatocytes, fibro-
blasts, A431, and endothelial cells via smooth, non–clath-
rin-coated membrane invaginations characteristic of cave-
olae (Montesanto et al., 1982; Tran et al., 1987; Parton et al.,
1994; Schnitzer et al., 1996). The biological plausibility of
such a hypothesis is emphasized by evidence that caveolae
mediate endocytosis of albumin, alkaline phosphatase,
protectin (CD59), and SV-40 virus in endothelial, epider-
moid A431, Jurkat T-lymphocyte, and CV1 cell systems
(Parton et al., 1994; Schnitzer et al., 1994; Deckert et al.,
1996; Stang et al., 1997); that endothelial caveolae contain
the transport machinery for vesicular traffic (Schnitzer et al.,
1995a, 1996); and that both GM1 and caveolin-1 likely re-
cycle between the plasma membrane and trans-Golgi in
murine NCTC 2071 and rat glioma C6 cells (GM1) (Fish-
man et al., 1983) and in canine MDCK cells and human
fibroblasts (VIP-21/caveolin-1) (Kurzchalia et al., 1992,
1994; Smart et al., 1994; Conrad et al., 1995).
These data also provide reason to suggest that caveolae-
like membrane domains may carry the CT–GM1 complex
sequentially from the site of toxin binding on the apical
membrane through endosomes to trans-Golgi of human
intestinal T84 cells, where the toxin may plausibly encoun-
ter KDEL-receptors. We do not envision, however, that
caveolae or caveolae-like detergent-insoluble membranes
in T84 cells necessarily form unique transport vesicles af-
ter endocytosis. Evidence from other cell systems indicates
that ligands internalized by non–clathrin-coated and clath-
rin-coated mechanisms ultimately merge in common intra-
cellular compartments (Tran et al., 1987; Hansen et al.,
1993). That detergent-insoluble membrane subdomains
are present on intracellular organelles and transport vesi-
cles (Brown and Rose, 1992; Harder et al., 1997) provides
further evidence that such structures may function along-
side classic transmembrane receptors to target membrane
components to specific sites within the vacuolar network
of eukaryotic cells. Whether CT–GM1 complexes in T84
cells remain associated with detergent-insoluble mem-
brane subdomains during transport into or beyond the api-
cal endosome, however, remains unknown.
In summary, the results of these studies show that signal
transduction by CT in polarized intestinal epithelial cells
depends on binding or clustering specifically the ganglio-
side GM1. Remarkably, toxin binding to the closely re-
lated ganglioside GD1a renders the toxin inactive in such
polarized epithelial cells. We also find that ganglioside
structure dictates toxin association with caveolae-like
membrane domains, and this is closely correlated with
toxin function. Thus, the mechanism(s) by which ganglio-
sides GM1 and GD1a function in signal transduction likely
depend on their ability to couple cholera and related heat-
labile enterotoxins with caveolae or caveolae-related mem-
brane subdomains in specific cell types.
We thank Pam Fredman and Jan Holmgren for providing data on ganglio-
side expression in T84 cells; Martin Carey and Karen Nibbering (Harvard
University Medical School, Boston, MA), and Randall Mrsny (Genen-
tech, South San Francisco, CA) for helpful discussions on lipid biochemis-
try; Focco van den Akker (University of Washington, Seattle, WA) for
advice on where to place the fusion joint in chimera 187; and J. Casanova
(Harvard University Medical School) and J. Holmgren for critical reading
of the manuscript.
This work was supported by T32-DK07477 (A. Wolf), National Insti-
tute of Health research grants DK 48106, DK/AI 53056 (W.I. Lencer), DK
35932, DK 33506 (J.L. Madara), AI 31940, AI14107 (R. Holmes), and the
Harvard Digestive Diseases Center DK 34854. Dr. Lencer is a recipient of
the Miles and Shirley Fitterman Basic Research Award from the Ameri-
can Digestive Health Foundation. 
Received for publication 2 October 1997 and in revised form 1 April 1998.
References
Anderson, R.G. 1993a. Caveolae: where incoming and outgoing messengers
meet. Proc. Natl. Acad. Sci. USA. 90:10909–10913.
Anderson, R.G. 1993b. Plasmalemmal caveolae and GPI-anchored membrane
proteins. Curr. Opin. Cell Biol. 5:647–652.
Anderson, R.G., B.A. Kamen, K.G. Rothberg, and S.W. Lacey. 1992. Potocyto-
sis: sequestration and transport of small molecules by caveolae. Science. 255:
410–411.
Bhatnagar, R.S., and J.I. Gordon. 1997. Understanding covalent modifications
of proteins by lipids: where cell biology and biophysics merge. Trends Cell
Biol. 7:14–20.
Bretscher, M.S., and S. Munro. 1993. Cholesterol and the Golgi apparatus. Sci-
ence. 261:1280–1281.
Brown, D.A., and J.K. Rose. 1992. Sorting of GPI-anchored proteins to gly-
colipid-enriched membrane subdomains during transport to the apical cell
surface. Cell. 68:533–544.
Chang, P.P., J. Moss, E.M. Twiddy, and R.K. Holmes. 1987. Type II heat-labile
enterotoxin of Escherichia coli activates adenylate cyclase in human fibro-
blasts by ADP ribosylation. Infect. Immun. 55:1854–1858.
Connell, T.D., and R.K. Holmes. 1992. Characterization of hybrid toxins pro-
duced in Escherichia coli by assembly of A and B polypeptides from Type I
and Type II heat-labile enterotoxins. Infect. Immun. 60:1653–1661.
Conrad, P.A., E.J. Smart, Y.-S. Ying, R.G.W. Anderson, and G.S. Bloom. 1995.
Caveolin cycles between plasma membrane caveolae and the Golgi complex
by microtubule-dependent and microtubule-independent steps. J. Cell Biol.
131:1421–1433.
Deckert, M., M. Ticchioni, and A. Bernard. 1996. Endocytosis of GPI-anchored
proteins in human lymphocytes: role of glycolipid-based domains, actin cy-
toskeleton, and protein kinases. J. Cell Biol. 133:791–799.
Dupree, P., R.G. Parton, G. Raposo, T.V. Kurzchalia, and K. Simons. 1993. Ca-
veolae and sorting in the trans-Golgi network of epithelial cells. EMBO
(Eur. Mol. Biol. Organ.) J. 12:1597–1605.
Fiedler, K., R.G. Parton, R. Kellner, T. Etzold, and K. Simons. 1994. VIP36, a
novel component of glycolipid rafts and exocytic carrier vesicles in epithelial
cells. EMBO (Eur. Mol. Biol. Organ.) J. 13:1729–1740.
Fishman, P.H, R.M. Bradley, B.E. Hom, and J. Moss. 1983. Uptake and metab-
olism of exogenous gangliosides by cultured cells: effect of choleragen on the
turnover of GM1. J. Lipid Res. 24:1002–1011.
French, C., E. Keshavarz-Moore, and J.M. Ward. 1996. Development of a sim-
ple method for the recovery of recombinant proteins from the Escherichia
coli periplasm. Enzyme Microb. Technol. 19:332–338.
Fukuta, S., J.L. Magnani, E.M. Twiddy, R.K. Holmes, and V. Ginsburg. 1988.
Comparison of the carbohydrate-binding specificities of cholera toxin and
Escherichia coli heat-labile enterotoxins LTh-I, LT-IIa, and LT-IIb. Infect.
Immun. 56:1748–1753.
Gorodinsky, A., and D.A. Harris. 1995. Glycolipid-anchored proteins in neuro-
blastoma cells form detergent-resistant complexes without caveolin. J. Cell
Biol. 129:619–627.
Guth, B.E.C., E.M. Twiddy, L.R. Trabulsi, and R.K. Holmes. 1986. Variation in
chemical properties and antigenic determinants among type II heat-labile
enterotoxins of Escherichia coli. Infect. Immun. 54:529–536.
Hakomori, S. 1983. Chemistry of glycosphingolipids. In Sphingolipid Biochem-
istry. J.N. Kanfer and S. Hakomori, editors. Plenum Press, New York. 1–166.
Hanada, K., M. Nishijima, Y. Akamatsu, and R.E. Pagano. 1995. Both sphin-
golipids and cholesterol participate in the detergent insolubility of alkaline
phosphatase, a glycosylphosphatidylinositol-anchored protein, in mamma-
lian membranes. J. Biol. Chem. 270:6254–6260.Wolf et al. Sorting of Cholera Toxin by Ganglioside GM1 927
Hansen, S.H., K. Sandvig, and B. van Deurs. 1993. Molecules internalized by
clathrin-independent endocytosis are delivered to endosomes containing
transferrin receptors. J. Cell Biol. 123:89–97.
Harder, T., R. Kellner, R.G. Parton, and J. Gruenberg. 1997. Specific release of
membrane-bound annexin II and cortical cytoskeleton elements by seques-
tration of membrane cholesterol. Mol. Biol. Cell. 8:533–545.
Holmes, R.K., and E.M. Twiddy. 1983. Characterization of monoclonal anti-
bodies that react with unique and cross-reacting determinants of cholera en-
terotoxin and its subunits. Infect. Immun. 42:914–923.
Holmes, R.K., E.M. Twiddy, and C.L. Pickett. 1986. Purification and character-
ization of type II heat-labile enterotoxin of Escherichia coli. Infect. Immun.
53:464–473.
Huang, C., J.R. Hepler, L.T. Chen, A.G. Gilman, R.G.W. Anderson, and S.M.
Mumby. 1997. Organization of G proteins and adenylyl cyclase at the plasma
membrane. Mol. Biol. Cell. 8:2365–2378.
Jobling, M.G., L.M. Palmer, J.L. Erbe, and R.K. Holmes. 1997. Construction
and characterization of versatile cloning vectors for efficient delivery of na-
tive foreign proteins to the periplasm of Escherichia coli. Plasmid. 38:158–173.
Kurzchalia, T.V., P. Dupree, and S. Monier. 1994. VIP21-Caveolin, a protein of
the trans-Golgi network and caveolae. FEBS Lett. 346:88–91.
Kurzchalia, T.V., P. Dupree, R.G. Parton, R. Kellner, H. Virta, M. Lehnert,
and K. Simons. 1992. VIP21, a 21-kD membrane protein is an integral com-
ponent of trans-Golgi-network–derived transport vesicles. J. Cell Biol. 118:
1003–1014.
Lee, C.-M., P.P. Chang, S.-C. Tsai, R. Adamik, S.R. Price, B.C. Kunz, J. Moss,
E.M. Twiddy, and R.K. Holmes. 1991. Activation of Escherichia coli heat-
labile enterotoxins by native and recombinant adenosine diphosphate-ribo-
sylation factors, 20-kD guanine nucleotide-binding proteins. J. Clin. Invest.
87:1780–1786.
Lencer, W.I., C. Delp, M.R. Neutra, and J.L. Madara. 1992. Mechanism of chol-
era toxin action on a polarized human epithelial cell line: role of vesicular
traffic. J. Cell Biol. 117:1197–1209.
Lencer, W.I., J.B. de Almeida, S. Moe, J.L. Stow, D.A. Ausiello, and J.L. Ma-
dara. 1993. Entry of cholera toxin into polarized human intestinal epithelial
cells: identification of an early brefeldin A sensitive event required for A1-
peptide generation. J. Clin. Invest. 92:2941–2951.
Lencer, W.I., C. Constable, S. Moe, M. Jobling, H.M. Webb, S. Ruston, J.L.
Madara, T. Hirst, and R. Holmes. 1995a. Targeting of cholera toxin and E.
coli heat labile toxin in polarized epithelia: role of COOH-terminal KDEL.
J. Cell Biol. 131:951–962.
Lencer, W.I., S. Moe, P.A. Rufo, and J.L. Madara. 1995b. Transcytosis of chol-
era toxin subunits across model human intestinal epithelia. Proc. Natl. Acad.
Sci. USA. 92:10094–10098.
Lencer, W.I., G. Strohmeier, S. Moe, S.L. Carlson, C.T. Constable, and J.L. Ma-
dara. 1995c. Signal transduction by cholera toxin: processing in vesicular
compartments does not require acidification. Am. J. Physiol. 269:G548–
G557.
Lencer, W.I., C. Constable, S. Moe, P.A. Rufo, A. Wolf, M.G. Jobling, S.P.
Ruston, J.L. Madara, R.K. Holmes, and T.R. Hirst. 1997. Proteolytic activa-
tion of cholera toxin and Escherichia coli labile toxin by entry into host epi-
thelial cells: signal transduction by a protease-resistant toxin variant. J. Biol.
Chem. 272:15562–15568.
Lisanti, M.P., P.E. Scherer, Z. Tang, and M. Sargiacomo. 1994. Caveolae, cave-
olin and caveolin-rich membrane domains: a signalling hypothesis. Trends
Cell Biol. 4:231–235.
Liu, J., P. Oh, T. Horner, R.A. Rodgers, and J.E. Schnitzer. 1997. Organized en-
dothelial cell surface signal transduction in caveolae distinct from glyco-
sylphosphatidylinositol-anchored protein microdomains. J. Biol. Chem. 272:
7211–7222.
Majoul, I.V., P.I.H. Bastiaens, and H.-D. Soling. 1996. Transport of an external
Lys-Asp-Glu-Leu (KDEL) protein from the plasma membrane to the endo-
plasmic reticulum: studies with cholera toxin in Vero cells. J. Cell Biol. 133:
777–789.
Mayor, S., and F.R. Maxfield. 1995. Insolubility and redistribution of GPI-
anchored proteins at the cell surface after detergent treatment. Mol. Biol.
Cell. 6:929–944.
Montesanto, R., J. Roth, and L. Orci. 1982. Non-coated membrane invagina-
tions are involved in binding and internalization of cholera and tetanus tox-
ins. Nature. 296:651–653.
Orlandi, P.A. 1997. Protein-disulfide isomerase-mediated reduction of the A
subunit of cholera toxin in a human intestinal cell line. J. Biol. Chem. 272:
4591–4599.
Orlandi, P.A., P.K. Curran, and P.H. Fishman. 1993. Brefeldin A blocks the re-
sponse of cultured cells to cholera toxin: implications for intracellular traf-
ficking in toxin action. J. Biol. Chem. 268:12010–12016.
Pacuszka, Y., R.M. Bradley, and P.H. Fishman. 1991. Neoglycolipid analogues
of ganglioside GM1 as functional receptors of cholera toxin. Biochemistry. 30:
2563–2570.
Parton, R.G. 1994. Ultrastructural localization of gangliosides: GM1 is concen-
trated in caveolae. J. Histochem. Cytochem. 42:155–166.
Parton, R.G., B. Joggerst, and K. Simons. 1994. Regulated internalization of ca-
veolae. J. Cell Biol. 127:1199–1215.
Parton, R.G., and K. Simons. 1995. Digging into caveolae. Science. 269:1398–
1399.
Rehm, A., and H.L. Ploegh. 1997. Assembly and intracellular targeting of the
bg subunits of heterotrimeric G proteins. J. Cell Biol. 137:305–317.
Rodgers, W., and J.K. Rose. 1996. Exclusion of CD45 inhibits activity of p56lck
associated with glycolipid-enriched membrane domains. J. Cell Biol. 135:
1515–1523.
Rothberg, K.G., Y.-S. Ying, B.A. Kamen, and R.G.W. Anderson. 1990. Choles-
terol controls the clustering of the glycospholipid-anchored membrane re-
ceptor for 5-methyltetrahydrofolate. J. Cell Biol. 111:2931–2938.
Sandvig, K., M. Ryd, Ø. Garred, E. Schweda, P.K. Holm, and B. van Deurs.
1994. Retrograde transport from the Golgi complex to the ER of both shiga
toxin and the nontoxic shiga B-fragment is regulated by buteric acid and
cAMP. J. Cell Biol. 126:53–64.
Schnaar, R.L., and L.K. Needham. 1994. Thin-layer chromatography of gly-
cosphingolipids. Methods Enzymol. 230:371–389.
Schnitzer, J.E., P. Oh, E. Pinney, and J. Allard. 1994. Filipin-sensitive caveolae-
mediated transport in endothelium: reduced transcytosis, scavenger endocy-
tosis, and capillary permeability of select macromolecules. J. Cell Biol. 127:
1217–1232.
Schnitzer, J.E., J. Liu, and P. Oh. 1995a. Endothelial caveolae have the molecu-
lar transport machinery for vesicle budding, docking, and fusion including
VAMP, NSF, SNAP, annexins, and GTPases. J. Biol. Chem. 270:14399–
14404.
Schnitzer, J.E., D.P. McIntosh, A.M. Dvorak, J. Liu, and P. Oh. 1995b. Separa-
tion of caveolae from associated microdomains of GPI-anchored proteins.
Science. 269:1435–1439.
Schnitzer, J.E., P. Oh, B.S. Jacobson, and A.M. Dvorak. 1995c. Caveolae from
luminal plasmalemma of rat lung endothelium: microdomains enriched in
caveolin, Ca21-ATPase, and inositol trisphosphate receptor. Proc. Natl.
Acad. Sci. USA. 92:1759–1763.
Schnitzer, J.E., P. Oh, and D.P. McIntosh. 1996. Role of GTP hydrolysis in fis-
sion of caveolae directly from plasma membranes. Science. 274:239–242.
Schroeder, R., E. London, and D. Brown. 1994. Interactions between saturated
acyl chains confer detergent resistance on lipids and glycosylphosphatidyli-
nositol (GPI)-anchored proteins: GPI-anchored proteins in liposomes and
cells show similar behavior. Proc. Natl. Acad. Sci. USA. 91:12130–12134.
Sharom, F.J., and C.W.M. Grant. 1978. A model for ganglioside behavior in cell
membranes. Biochim. Biophys. Acta. 507:280–293.
Shenoy-Scaria, A.M., D.J. Dietzen, J. Kwong, D.C. Link, and D.M. Lublin.
1994. Cysteine3 of Src family protein tyrosine kinases determines palmitoy-
lation and localization in caveolae. J. Cell Biol. 126:353–363.
Simons, K., and E. Ikonen. 1997. Functional rafts in cell membranes. Nature.
387:569–572.
Simons, K., and G. van Meer. 1988. Lipid sorting in epithelial cells. Biochemis-
try. 27:6197–6202.
Simons, K, and A. Wandinger-Ness. 1990. Polarized sorting in epithelia. Cell.
62:207–210.
Sixma, T.K., S.E. Pronk, H.H. Kalk, E.S. Wartna, B.A.M. van Zanten, B.
Witholt, and W.G.J. Hol. 1991. Crystal structure of a cholera toxin-related
heat-labile enterotoxin from E. coli. Nature. 351:371–377.
Smart, E.J., Y.-S. Ying, P.A. Conrad, and R.G. Anderson. 1994. Caveolin
moves from caveolae to the Golgi apparatus in response to cholesterol oxi-
dation. J. Cell Biol. 127:1185–1197.
Spangler, B.D. 1992. Structure and function of cholera toxin and the related Es-
cherichia coli heat-labile enterotoxin. Microbiol. Rev. 56:622–647.
Stan, R.-V., W.G. Roberts, D. Predescu, K. Ihida, L. Saucan, L. Ghitescu, and
G.E. Palade. 1997. Immunoisolation and partial characterization of endothe-
lial plasmalemmal vesicles (caveolae). Mol. Biol. Cell. 8:595–605.
Stang, E., J. Kartenbeck, and R.G. Parton. 1997. Major histocompatibility com-
plex class I molecules mediate association of SV40 with caveolae. Mol. Biol.
Cell. 8:47–57.
Strohmeier, G.R., W.I. Lencer, T.W. Patapoff, L.F. Thompson, S.L. Carlson,
S.J. Moe, D. Carnes, R.J. Mrsny, and J.L. Madara. 1997. Surface expression,
polarization, and functional significance of CD73 in human intestinal epithe-
lia. J. Clin. Invest. 99:2588–2601.
Thomas, J.L., D. Holowka, B. Baird, and W.W. Webb. 1994. Large–scale co-
aggregation of fluorescent lipid probes with cell surface proteins. J. Cell Biol.
125:795–802.
Thompson, T.E., and T.W. Tillack. 1985. Organization of glycosphingolipids in
bilayers and plasma membranes of mammalian cells. Annu. Rev. Biophys.
Bioeng. 14:361–386.
Tran, D., J.-L. Carpentier, F. Sawano, P. Gorden, and L. Orci. 1987. Ligands in-
ternalized through coated or noncoated invaginations follow a common in-
tracellular pathway. Proc. Natl. Acad. Sci. USA. 84:7956–7961.
van den Akker, F., S. Sarfaty, E.M. Twiddy, T.D. Connell, R.K. Holmes, and
W.G.J. Hol. 1996. Crystal structure of a new heat-labile enterotoxin, LTIIb.
Structure (Lond.). 4:665–678.
van Genderen, I.L., and G. van Meer. 1993. Lipid sorting—measurement and
interpretation. Biochem. Soc. Trans. 21:235–239.
van Meer, G. 1993. Transport and sorting of membrane lipids. Curr. Opin. Cell
Biol. 5:661–673.
van Meer, G., and G.E. Palade. 1989. Lipid traffic in animal cells. Annu. Rev.
Cell Biol. 5:247–275.
Zhang, R.-G., D.L. Scott, M.L. Westbrook, S. Nance, B.D. Spangler, G.G. Ship-
ley, and E.M. Westbrook. 1995. The three-dimensional crystal structure of
cholera toxin. J. Mol. Biol. 251:563–573.